3Libby P. Inflammation in atherosclerosis [J]. Nature, 2002,420(6917) :868 -874.
4Williams KJ, Tabas I. Atherosclerosis and inflammation [J]. Science,2002,297(5581) :521 -522.
5Blankenberg S, Luc G, Ducimetiere P, et al. PRIME study group.interleukin-18 and the risk of coronary heart disease in European men: the prospective epidemiological study of myocardial infarction (PRIME) [J]. Circulation, 2003, 108 (20) :2453 -2459.
6Blankenberg S, Tiret L, Bickel C, et al. Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina[J].Circulation, 2002,106(1) :24 -30.
7Okamura H, Tsutsi H, Komatsu T, et al. Cloning of a new cytokine that induces IFN-gamma production by T cells[J]. Nature, 1995,378(6552) :88 -91.
8Ushio S, Namba M, Okura T, et al. Cloning of the cDNA for human IFN-gamma-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. [J]. lmmunol,1996,156( 11 ) :4274 -4279.
9Whitman SC, Ravisankar P, Daugherty A. Interleukin-18 enhances atherosclerosis in apolipoprotein E(-/-) mice through release of interferon-gamma[ J]. Circ Rcs,2002,90(2) :E34 -E38.
10Elhage R, Jawien J, Rudling M, et al. Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice [J]. Cardiovasc Res,2003,59(1) :234 -240.
